Welcome to our dedicated page for Kardigan SEC filings (Ticker: KARD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Kardigan's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Kardigan's regulatory disclosures and financial reporting.
Kardigan, Inc. adopted a third amended and restated certificate of incorporation in connection with its initial public offering. The new charter authorizes 700,000,000 shares of common stock, including 500,000,000 voting shares and 200,000,000 non-voting shares, plus 10,000,000 shares of undesignated preferred stock that the board may issue in series.
The charter also removes prior preferred stock series and ends stockholder rights to act by written consent or to call special meetings. Kardigan simultaneously implemented amended and restated bylaws that set formal meeting procedures, advance notice rules for proposals and director nominations, and align with the updated charter.
Kardigan, Inc. insiders associated with HRTG funds converted multiple series of redeemable convertible preferred stock into Common Stock on June 17, 2026. The Series A, Series B and Series B-1 preferred shares all automatically converted into Common Stock on a 1.5928-to-1 basis when Kardigan’s Form S-1 registration statement became effective, without additional cash payment. Following these conversions, HRTG PV, L.P. held 11,741,868 Common Stock shares indirectly and HRTG CIF 2024, L.P. held 2,050,166 shares indirectly. The filing reports derivative conversions only, with no open-market purchases or sales.
Kardigan, Inc. reported that investment entity ARCH Venture Fund XIII, L.P. converted its preferred equity into common stock in connection with Kardigan’s initial public offering. On June 17, 2026, all Series A, Series B, and Series B-1 Preferred Stock automatically converted into common shares on a 1.5928-for-1 basis upon effectiveness of Kardigan’s Form S-1, with no cash paid. Following these conversions, ARCH Venture Fund XIII, L.P. indirectly holds 13,792,035 shares of Common Stock. The filing notes that related ARCH entities and investment committee members may be deemed beneficial owners but disclaim beneficial ownership beyond any pecuniary interest.
Pasternak Andy reported acquisition or exercise transactions in this Form 4 filing.
Kardigan, Inc.'s Chief Strategy Officer Andy Pasternak received a grant of 79,640 restricted stock units, each representing one share of common stock at no purchase price. These RSUs vest in full on June 17, 2028, contingent on his continued service, and equal his reported direct holdings after the grant.
Meeker David P reported acquisition or exercise transactions in this Form 4 filing.
Kardigan, Inc. director David P. Meeker received an equity grant of 20,706 restricted stock units (RSUs). Each RSU represents the right to receive one share of Kardigan common stock at a later date rather than cash today.
The RSUs vest in full on June 17, 2028, as long as Meeker continues to provide service to the company through that date. Following this award, he is reported as holding 20,706 shares or share-equivalent units directly, reflecting a compensation-related equity grant rather than an open-market purchase or sale.
Kardigan, Inc. director and 10% owner Paul L. Berns reported equity acquisitions tied to Kardigan’s initial public offering and a new board grant. He received 20,706 shares of Common Stock at no cost as a restricted stock unit award, with all RSUs vesting on June 17, 2028, subject to continuous service.
In connection with the IPO, ARCH Venture Fund XIII, L.P., an investment fund associated with Berns, converted its Series A, Series B and Series B-1 Preferred Stock into 13,792,035 shares of Common Stock on a 1.5928-for-1 basis, automatically and without payment of consideration. These shares are held by ARCH XIII, with related general partners and committee members, including Berns, potentially deemed beneficial owners subject to pecuniary-interest limitations.
Moriarty John B reported acquisition or exercise transactions in this Form 4 filing.
Kardigan, Inc. reported that Chief Legal Officer John B. Moriarty received an equity award in the form of 47,784 shares of common stock, represented by restricted stock units. The grant was made at a stated price of $0.00 per share as a compensation award rather than a market purchase.
Each restricted stock unit represents a contingent right to receive one share of common stock upon settlement. The units vest in full on June 17, 2028, provided Moriarty remains in continuous service with the company through that vesting date. Following this grant, he directly holds 47,784 shares subject to these vesting conditions.
Jahn Brianne reported acquisition or exercise transactions in this Form 4 filing.
Kardigan, Inc. reported that its Chief Financial Officer, Brianne Jahn, received a grant of 79,640 shares of common stock in the form of restricted stock units. The award was granted at no cash cost per share and is compensation rather than an open-market purchase.
The RSUs vest in full on June 17, 2028, as long as the executive remains in continuous service through that date. After this grant, the filing shows total direct holdings of 79,640 common shares tied to this award.
Popovits Kimberly J reported acquisition or exercise transactions in this Form 4 filing.
Kardigan, Inc. director Kimberly J. Popovits received an equity award of 20,706 restricted stock units. Each RSU represents a contingent right to receive one share of Kardigan common stock upon settlement. The RSUs vest in full on June 17, 2028, if she remains in continuous service through that date, and her direct holdings after this grant are 20,706 shares-equivalent.
Kardigan, Inc. director Timothy P. Walbert reported receiving new equity awards consisting of restricted stock units and stock options as part of his compensation. He was granted 20,706 RSUs, each representing one share of common stock that vests in full on June 17, 2028, assuming he continues in service through that date. He also received stock options covering 57,573 shares of common stock at an exercise price of $16.00 per share, vesting in 36 equal monthly installments starting June 17, 2026 and expiring on June 16, 2036. After these awards, his reported direct holdings from this grant are 20,706 shares of common stock and options for 57,573 shares.